~~<i id='F2CDB84CEB'><strike id='F2CDB84CEB'><tt id='F2CDB84CEB'><pre id='F2CDB84CEB'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：comprehensive 2025-10-02 16:41:01 Page View：2576

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Yancopoulos of Regeneron works to expand Dupixent success
Next article： Moonlake's readout produced a cash windfall. Risks remain

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Readout Newsletter: Illumina, CRISPR, Regeneron

AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

After John Oliver segment, STAT readers share their opioid

STATWhencomedian JohnOliver tookpharmacompaniestotask onhisHBOshowSundayfortheirmarketingofpowerfuln

WSS

hotspot

hotspot

leisure time

knowledge

After John Oliver segment, STAT readers share their opioid